美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Baillie Gifford International Alpha ETF

25.23

+0.01060.04%

成交量：8

成交额：201

市值：3.28亿

市盈率：- -

高：25.23

开：25.22

低：25.23

收：25.22

52周最高：25.97

52周最低：23.97

股本：1,301.20万

流通股本：1,301.20万

量比：0.00

换手率：0.00%

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

诺和诺德(NVO.US)考虑进军脱发市场，“后Wegovy”战略寻求新增长点

诺和诺德(NVO.US)考虑进军脱发市场，“后Wegovy”战略寻求新增长点

阿斯麦高管：未在欧洲大陆销售芯片制造设备

肥胖药赛道，礼来与诺和诺德迎来挑战者？

环球市场播报

诺和诺德投资者日遭市场冷遇公司回应司美格鲁肽“回流药”事件

每日经济新闻

诺和诺德CEO：对收购持开放态度，以强化减重药物管线

诺和诺德资本市场日遇冷：CEO坦言承诺太多、兑现不足，必须重建投资者信心

ASML高管直言：欧洲本土光刻机销量为零，半导体产业面临掉队风险

欧洲市值最高企业阿斯麦(ASML.US)执行副总裁Frank Heemskerk表示，公司目前没有在欧洲销售任何芯片制造

ASML高管表示，欧洲最大的企业没有在欧洲销售。

诺和诺德承诺在2030年前向联合国儿童基金会肥胖症防治计划投入1800万美元。

诺和诺德回应司美格鲁肽“回流药”问题，称配合监管严厉打击

诺和诺德回应司美格鲁肽"回流药"事件：支持并全力配合打击非法行为，推进药品全链路追溯

诺和诺德(NVO.US)资本市场日遇冷：CEO坦言承诺太多、兑现不足，必须重建投资者信心

诺和诺德CEO：公司需付出更多努力赢得投资者信任

“减肥神药”被指控损伤视力，1700亿美元市值诺和诺德被数十名美国患者起诉，公司股价较高点已跌逾70%

每日经济新闻

诺和诺德CEO：正在成瘾等领域测试GLP-1药物。

诺和诺德首席执行官：仍需努力重建投资者信心。

央视曝光变质“回流药”！诺和诺德：支持严厉打击，保障用药安全

诺和诺德回应“司美回流药”：支持并全力配合打击非法行为继续推进授权认证渠道体系

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/BGIA/news?page=6"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BGIA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BGIA\",,,,,undefined,":{"symbol":"BGIA","market":"US","secType":"STK","nameCN":"Baillie Gifford International Alpha ETF","latestPrice":25.2294,"timestamp":1791921600000,"preClose":25.2188,"halted":0,"volume":8,"delay":0,"changeRate":0.00042032134756596714,"floatShares":13012033,"shares":13012033,"eps":0,"marketStatus":"已收盘","change":0.0106,"latestTime":"10-13 16:00:00 EDT","open":25.2188,"high":25.2294,"low":25.2294,"amount":201,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791964800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":25.2188,"bidAskSpread":0,"volumeRatio":0.002641},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BGIA\",,,,,undefined,":{"symbol":"BGIA","floatShares":13012033,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.002641,"shares":13012033,"dividePrice":0,"high":25.2294,"amplitude":0,"preClose":25.2188,"low":25.2294,"week52Low":23.9707,"pbRate":"--","week52High":25.97,"institutionHeld":0,"latestPrice":25.2294,"eps":0,"divideRate":0,"volume":8,"delay":0,"ttmEps":0,"open":25.2188,"prevYearClose":25.2,"prevWeekClose":25.3417,"prevMonthClose":24.9683,"prevQuarterClose":24.9683,"fiveDayClose":25.4651,"twentyDayClose":24.9961,"sixtyDayClose":24.2745},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BGIA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BGIA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BGIA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BGIA\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669734401","title":"诺和诺德(NVO.US)考虑进军脱发市场，“后Wegovy”战略寻求新增长点","url":"https://stock-news.laohu8.com/highlight/detail?id=2669734401","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669734401?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 08:14","pubTimestamp":1790122468,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669173428","title":"诺和诺德(NVO.US)考虑进军脱发市场，“后Wegovy”战略寻求新增长点","url":"https://stock-news.laohu8.com/highlight/detail?id=2669173428","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669173428?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 08:14","pubTimestamp":1790122468,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺和诺德正将目光投向脱发市场——这家 Ozempic 生产商正寻求多元化，作为其“后 Wegovy”增长战略的一部分。在上述言论发表一天前，诺和诺德刚刚公布了其“后 Wegovy”增长战略——彼时 GLP-1 市场正日益拥挤。不过，脱发并不在诺和诺德计划于今年晚些时候或明年年初开展中期试验的八个适应症之列。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499620.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669731201","title":"阿斯麦高管：未在欧洲大陆销售芯片制造设备","url":"https://stock-news.laohu8.com/highlight/detail?id=2669731201","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669731201?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 08:11","pubTimestamp":1790122285,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，荷兰光刻机企业阿斯麦执行副总裁 Frank Heemskerk 表示，公司目前没有在欧洲大陆销售任何芯片制造设备。他称：“我们在欧洲完全没有销售任何东西。这是因为欧洲没有进行投资，也没有新的芯片工厂在这里建设。”数据显示，今年第二季度欧洲对阿斯麦净系统销售额的贡献为零，2025 年欧洲、中东和非洲地区占 1%。上半年韩国是该公司设备最大的市场。Heemskerk 表示，其他国家会铺上最红的地毯邀请投资建厂，阿斯麦目前约四分之一的研发工作在美国进行。欧盟正在对 2023 年生效的《芯片法案》进行改革。今年 5 月，阿斯麦与印度塔塔电子签署协议，将协助印度建设半导体工厂。 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2291622","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LRCU","BGIA","LRCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669125904","title":"肥胖药赛道，礼来与诺和诺德迎来挑战者？","url":"https://stock-news.laohu8.com/highlight/detail?id=2669125904","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669125904?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 00:04","pubTimestamp":1790093040,"startTime":"0","endTime":"0","summary":"Viking Therapeutics周二早盘股价大涨 31%。该公司公布旗下糖尿病及肥胖候选药物 VK2735 的最新研究主要终点阳性结果。用药 21 周后，受试者体重下降幅度达到 16%19%，疗效可以与礼来、诺和诺德的同类竞品相匹敌。VK2735 靶向的激素受体与礼来的 Zepbound、Mounjaro 一致，为每周注射一次制剂。在这项试验中，2 型糖尿病受试者用药 48 周，体重平均下降 15.5%，血糖水平同样大幅改善。礼来与诺和诺德目前在肥胖药物市场占据巨大领先地位，但两家公司股票最新交易均下跌 1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-23/doc-inistrnt8779440.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669128452","title":"诺和诺德投资者日遭市场冷遇 公司回应司美格鲁肽“回流药”事件","url":"https://stock-news.laohu8.com/highlight/detail?id=2669128452","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669128452?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 22:29","pubTimestamp":1790087391,"startTime":"0","endTime":"0","summary":"9月21日，诺和诺德在伦敦举办投资者日（CapitalMarketsDay）活动，新任CEO（首席执行官）MikeDoustdar首次完整阐述公司长期战略。公司公布2030年战略目标，包括收入增速“与行业同行保持一致”、2035年前管线销售额超1500亿丹麦克朗（约230亿美元）、2030年前推出超5款“超级重磅炸弹”级新药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609223881552768.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609223881552768.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669476381","title":"诺和诺德CEO：对收购持开放态度，以强化减重药物管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2669476381","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669476381?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:26","pubTimestamp":1790083566,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["OZEM","NVOH","BGIA","NVOX","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669987110","title":"诺和诺德资本市场日遇冷：CEO坦言承诺太多、兑现不足，必须重建投资者信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2669987110","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669987110?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:13","pubTimestamp":1790082780,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺和诺德首席执行官迈克·杜斯塔尔周二在一次采访中表示，公司必须付出更多努力来重建投资者信心，因为这家Ozempic制造商旗下最大药物将在下一个十年初面临专利悬崖。诺和诺德股价周一出现下挫，因为这家丹麦制药公司的资本市场日让投资者对其转型计划的细节缺失感到失望。诺和诺德承诺到2030年推出五款以上重磅新药，到2035年新增销售额超过230亿美元。","market":"fut","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499312.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BGIA","NVOX","NVOH","NVO","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669481140","title":"ASML高管直言：欧洲本土光刻机销量为零，半导体产业面临掉队风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2669481140","media":"IT之家","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669481140?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:11","pubTimestamp":1790082663,"startTime":"0","endTime":"0","summary":"IT之家 9 月 22 日消息，据彭博社报道，欧洲市值最高的企业阿斯麦 的一名高层表示，该公司并未在欧洲大陆销售任何芯片制造设备；在美国、中国、印度都在大举投入建设本土半导体产业的背景之下，欧洲正面临被甩在身后的风险。欧盟正在重新修订《欧洲芯片法案》。IT之家注意到，二季度阿斯麦整机净销售额当中，来自欧洲地区的贡献为零。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8wdPkYg3LOi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["ASMG","QQQA","ASMU","ASMZ","BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669104144","title":"欧洲市值最高企业阿斯麦(ASML.US)执行副总裁Frank Heemskerk表示，公司目前没有在欧洲销售任何芯片制造","url":"https://stock-news.laohu8.com/highlight/detail?id=2669104144","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669104144?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 20:31","pubTimestamp":1790080308,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SEMI","BGIA","LINT","INT","BK4138","INYY","INTW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141431","title":"ASML高管表示，欧洲最大的企业没有在欧洲销售。","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141431","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141431?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 20:01","pubTimestamp":1790078462,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669480141","title":"诺和诺德承诺在2030年前向联合国儿童基金会肥胖症防治计划投入1800万美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2669480141","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669480141?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078458,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669143364","title":"诺和诺德回应司美格鲁肽“回流药”问题，称配合监管严厉打击","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143364","media":"第一财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143364?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 17:30","pubTimestamp":1790069426,"startTime":"0","endTime":"0","summary":"作为降糖减肥领域的明星药物，诺和诺德的司美格鲁肽近日被曝出成回流药重灾区。根据央视新闻近日报道称，广州医保部门依托“药品追溯码”大数据模型预警，对可疑人员就医轨迹深入研判，经过缜密摸排、连续蹲守，联合公安机关开展专项行动，成功打掉一个收药倒药的犯罪团伙。在一处仓库内，医保和公安发现，30多摄氏度的闷热潮湿环境中，本该冷链保存的药品被常温零散摆放。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609223881330182.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609223881330182.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669100961","title":"诺和诺德回应司美格鲁肽\"回流药\"事件：支持并全力配合打击非法行为，推进药品全链路追溯","url":"https://stock-news.laohu8.com/highlight/detail?id=2669100961","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669100961?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 17:14","pubTimestamp":1790068440,"startTime":"0","endTime":"0","summary":"9月22日，针对近期司美格鲁肽“回流药”相关报道，诺和诺德中国对中国证券报.中证金牛座记者表示，公司始终将患者安全置于首位，坚决支持并全力配合国家有关部门依法对医保“回流药”等非法 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260922/c680174356.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260922/c680174356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669922110","title":"诺和诺德(NVO.US)资本市场日遇冷：CEO坦言承诺太多、兑现不足，必须重建投资者信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2669922110","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669922110?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 17:11","pubTimestamp":1790068317,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669114267","title":"诺和诺德CEO：公司需付出更多努力赢得投资者信任","url":"https://stock-news.laohu8.com/highlight/detail?id=2669114267","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669114267?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 15:46","pubTimestamp":1790063218,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669112335","title":"“减肥神药”被指控损伤视力，1700亿美元市值诺和诺德被数十名美国患者起诉，公司股价较高点已跌逾70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669112335","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669112335?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 15:41","pubTimestamp":1790062915,"startTime":"0","endTime":"0","summary":"凭借司美格鲁肽系列降糖、减重药物走红的医药巨头诺和诺德，正陷入多重经营困境。近期，数十名美国患者集体起诉诺和诺德，指控该公司旗下司美格鲁肽类药物引发严重视力损伤，相关案件已进入美国联邦法院集中审理。在美国的诉讼爆发之前，丹麦也出现了88起类似的理赔申请案例。目前，欧洲监管机构已经将非动脉炎性前部缺血性视神经病变（NAION）列为司美格鲁肽药物的“非常罕见”副作用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609223881226257.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609223881226257.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669685119","title":"诺和诺德CEO：正在成瘾等领域测试GLP-1药物。","url":"https://stock-news.laohu8.com/highlight/detail?id=2669685119","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669685119?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 14:39","pubTimestamp":1790059169,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOH","BGIA","RSPH","NVOC","JDOC","THNR","NVOX","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669119585","title":"诺和诺德首席执行官：仍需努力重建投资者信心。","url":"https://stock-news.laohu8.com/highlight/detail?id=2669119585","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669119585?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 14:33","pubTimestamp":1790058799,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669116956","title":"央视曝光变质“回流药”！诺和诺德：支持严厉打击，保障用药安全","url":"https://stock-news.laohu8.com/highlight/detail?id=2669116956","media":"同花顺","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669116956?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 14:07","pubTimestamp":1790057220,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者韩利明央视《新闻调查》揭秘：医保开药被药贩低价回收，常温堆在闷热仓库，却用泡沫箱伪装冷链，在网上低价倒卖——涉案数量最多的就是司美格鲁肽，查扣8000余盒。诺和诺 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260922/c680163744.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260922/c680163744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669055190","title":"诺和诺德回应“司美回流药”：支持并全力配合打击非法行为 继续推进授权认证渠道体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2669055190","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669055190?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 11:11","pubTimestamp":1790046660,"startTime":"0","endTime":"0","summary":"【诺和诺德回应“司美回流药”：支持并全力配合打击非法行为 继续推进授权认证渠道体系】9月22日，就司美格鲁肽“回流药”问题，诺和诺德中国向澎湃新闻记者表示，针对近期相关报道，公司始终将患者安全置于首位，一贯坚决支持并全力配合国家有关部门依法对医保回流药等非法行为进行严厉打击，以维护国家医保基金安全和患者合法权益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609223881063527.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609223881063527.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":199,"code":"91000000","status":"200"}]}}